CDIO

Cardio Diagnostics Holdings Inc

CDIO.US cdio.ai + Research + Basket
CIK 0001870144
Employees 15
Phone 855 226 9991
Fiscal year end December
IPO Jan 14, 2022
Address 311 West Superior Street, Chicago, IL, United States, 60654
1.65
+0.05 (+2.81%)
USD · NASDAQ
52-week range
0.97
7.91
Trading at 10% of the 52-week range
Market Cap
4.74M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
2.51
Div. Yield
N/A
% Institutions
6.52%
% Insiders
8.31%

1 Year

-54.6%

3 Year

-91.9%

10 Year

-99.4%
Description

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Actions

Add an action for CDIO.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Meeshanthini V. Dogan Ph.D. Co-Founder, CEO & Director 1989
Ms. Elisa Michael Luqman Esq., J.D., M.B.A. CFO & Principal Accounting Officer 1964
Mr. Timur Dogan Ph.D. Chief Technology Officer 1989
Dr. Robert A. Philibert M.D., Ph.D. Co-Founder, Chief Medical Officer & Director 1962

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Sep 06, 2024 Meeshanthini Dogan N/A Purchase 2.30K $8.70 $19.99K SEC
Sep 06, 2024 Robert Philibert N/A Purchase 1.14K $8.70 $9.87K SEC
Aug 31, 2023 Meeshanthini Dogan N/A Purchase 549.00 $16.50 $9.06K SEC
Aug 28, 2023 Robert Philibert N/A Purchase 600.00 $18.00 $10.80K SEC
Aug 25, 2023 Meeshanthini Dogan N/A Purchase 59.00 $16.80 $991.20 SEC
Aug 24, 2023 Robert Philibert N/A Purchase 533.00 $18.00 $9.59K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Renaissance Technologies Corp 49.20K Jun 30, 2026 1.66% $0.00 220.56%
BlackRock Inc 34.71K Jun 30, 2026 1.17% $0.00 0.00%
Geode Capital Management, LLC 26.23K Jun 30, 2026 0.89% $0.00 -18.47%
Vanguard Capital Management, LLC 20.16K Jun 30, 2026 0.68% $0.00 0.00%
Citadel Advisors Llc 19.07K Jun 30, 2026 0.64% $0.00 0.00%
XTX Topco Ltd 16.09K Jun 30, 2026 0.54% $0.00 0.00%
Jane Street Group LLC 11.93K Jun 30, 2026 0.40% $0.00 -85.32%
State Street Corp 10.10K Jun 30, 2026 0.34% $0.00 0.00%
Vanguard Fiduciary Trust Co 2.82K Jun 30, 2026 0.10% $0.00 -28.85%
Tower Research Capital LLC 1.81K Jun 30, 2026 0.06% $0.00 -17.47%
UBS Group AG 656.00 Jun 30, 2026 0.02% $0.00 -93.39%
Wolverine Asset Management LLC 104.00 Jun 30, 2026 0.00% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 100.00 Jun 30, 2026 0.00% $0.00 0.00%
SHP Wealth Management 16.00 Jun 30, 2026 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 16.00 Jun 30, 2026 0.00% $0.00 0.00%
SBI Securities Co Ltd 10.00 Jun 30, 2026 0.00% $0.00 0.00%
Wells Fargo & Co 2.00 Jun 30, 2026 0.00% $0.00 0.00%
Citigroup Inc 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Scientech Research LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
HRT FINANCIAL LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 15.66K 0.53% ▼ 0.53% Aug 31, 2026
2 Fidelity Series Total Market Index 2.83K 0.10% ▲ 0.00% Aug 31, 2026
3 Fidelity Total Market Index 2.25K 0.08% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $4.74M
EBITDA: $-6.08M
Book Value: $2.51
Earnings/Share: $-2.91
Profit Margin: 0.00%
Operating Margin: -27,950.50%
ROA (TTM): -44.06%
ROE (TTM): -75.44%
Revenue (TTM): $14.45K
Revenue/Share (TTM): $0.01
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -28.30%

Valuation Metrics

Enterprise Value: $-274.69K
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 2.96M
Shares Float: 2.84M
% Insiders: 8.31%
% Institutions: 6.52%
Shares Short: 2.97K
Shares Short (Prior Month): 1.01K
Short Ratio: 0.09
Short % Float: 0.10%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$14.83K
Cost of Goods Sold
adjust
$-398.13K
Gross Profit
subtotal
$14.83K
SG&A
adjust
$-5.03M
R&D
adjust
$-641.21K
Other Operating Expense
adjust
$-832.12K
Operating Income
subtotal
$-6.48M
Other / Non-Operating Items
adjust
$-14.09K
Net Income
subtotal
$-6.50M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CDIO.US!